TORIPALIMAB vs TRABECTEDIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TORIPALIMAB vs TRABECTEDIN: Safety Overview
| Metric | TORIPALIMAB | TRABECTEDIN |
|---|---|---|
| Total FAERS Reports | 1,344 | 1,957 |
| Deaths Reported | 65 | 376 |
| Death Rate | 4.8% | 19.2% |
| Hospitalizations | 823 | 896 |
| Average Patient Age | 58.0 yrs | 56.4 yrs |
| % Female Patients | 24.9% | 66.0% |
| FDA Approval Date | N/A | Oct 23, 2015 |
| Manufacturer | Coherus Oncology, Inc. | Janssen Products, LP |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Prescription |